<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-8-91-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-8-12-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neoplastic Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Craniopharyngioma: Recurrence Factors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>12</month>
<year>1994</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>06</month>
<year>2016</year>
</pub-date>
<volume>8</volume>
<issue>12</issue>
<fpage>91</fpage>
<lpage>91</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1994 The Author(s)</copyright-statement>
<copyright-year>1994</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1227/00006123-199412000-00001" vol="35" page="1001">
<article-title>Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Factors predictive of recurrence and functional outcome were determined in a retrospective clinicopathological analysis of 56 patients (26 children and 30 adults) operated on for craniopharyngioma since 1981 at New York University Medical Center.</p>
</abstract>
<kwd-group>
<kwd>Craniopharyngioma</kwd>
<kwd>Brain Invasion</kwd>
<kwd>Benign Neoplasms</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Factors predictive of recurrence and functional outcome were determined in a retrospective clinicopathological analysis of 56 patients (26 children and 30 adults) operated on for craniopharyngioma since 1981 at New York University Medical Center. Children underwent gross total resection (GTR) of tumor more frequently than adults (77% cf 27%). Tumors were almost all adamantinomatous in children, whereas in adults, two thirds were adamantinomatous and one third were squamous papillary. Brain invasion was most frequent with the adamantinomatous craniopharyngiomas; invasion had occurred in 46% of the children compared with 17% of adults. Subtotal resection was associated with a higher rate of recurrence compared with total resection. Brain invasion had no effect on recurrence rate in totally resected cases. Functional, visual, and endocrine outcomes were not sacrificed by total resection of tumor. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p>COMMENT. The single most important factor predictive of craniopharyngioma recurrence is the extent of surgical resection. Total compared to subtotal resection has a significantly lower recurrence rate without affecting functional outcome. Brain invasion does not predict higher recurrence provided the tumor is totally resected.</p>
<p><bold>Estogen Receptor Gene Expression.</bold> Craniopharyngiomas are histologically benign neoplasms of the sellar region that frequently show local invasion of brain tissue. In a collaborative study at the University of Toronto, Canada, the Mayo Clinic, and the University of Virginia, Charlottesville, 23 surgically removed craniopharyngiomas uniformally expressed the estrogen receptor gene. A possible hormonal component to the genesis and progression of craniopharyngiomas and investigation of hormonal therapy are suggested.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiner</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Wisoff</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Kupersmith</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zagzag</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome</article-title>
<source>Neurosurgery</source>
<year>1994</year>
<month>Dec</month>
<volume>35</volume>
<issue>6</issue>
<fpage>1001</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="doi">10.1227/00006123-199412000-00001</pub-id>
<pub-id pub-id-type="pmid">7885544</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>